Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 1
2011 1
2013 1
2015 2
2017 2
2018 3
2019 6
2020 8
2021 5
2022 6
2023 3
2024 6
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial.
Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, Bonzano E, Prisco A, Masiello V, La Rocca E, Spoto R, Becherini C, Blandino G, Moscetti L, Colciago RR, Audisio RA, Brain E, Caini S, Hamaker M, Kaidar-Person O, Lambertini M, Marrazzo L, Saieva C, Spanic T, Strnad V, Wheelwright S, Poortmans PMP, Livi L; EUROPA Trial Investigators. Meattini I, et al. Among authors: masiello v. Lancet Oncol. 2025 Jan;26(1):37-50. doi: 10.1016/S1470-2045(24)00661-2. Epub 2024 Dec 12. Lancet Oncol. 2025. PMID: 39675376 Clinical Trial.
The Assisi think tank focus review on postoperative radiation for lobular breast cancer.
Kaidar-Person O, Ratosa I, Franco P, Masiello V, Marazzi F, Pedretti S, Ciabattoni A, Leonardi MC, Tramm T, Coles CE, Meattini I, Arenas M, Offersen BV, Boersma LJ, Valentini V, Dodwell D, Poortmans P, Aristei C; Assisi Think Tank Meeting ATTM investigators. Kaidar-Person O, et al. Among authors: masiello v. Radiother Oncol. 2024 Dec;201:110573. doi: 10.1016/j.radonc.2024.110573. Epub 2024 Oct 11. Radiother Oncol. 2024. PMID: 39395669
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative Review.
Meattini I, Coles CE, Tramm T, Borghesi S, Krug D, Montero A, Nardone V, Salvestrini V, Valzano M, Valentini V, Aristei C, Poortmans P; Assisi Think Tank Meeting Investigators. Meattini I, et al. JAMA Oncol. 2025 Mar 1;11(3):329-339. doi: 10.1001/jamaoncol.2024.5780. JAMA Oncol. 2025. PMID: 39820307 Review.
The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer.
Aristei C, Kaidar-Person O, Boersma L, Leonardi MC, Offersen B, Franco P, Arenas M, Bourgier C, Pfeffer R, Kouloulias V, Bölükbaşı Y, Meattini I, Coles C, Luis AM, Masiello V, Palumbo I, Morganti AG, Perrucci E, Tombolini V, Krengli M, Marazzi F, Trigo L, Borghesi S, Ciabattoni A, Ratoša I, Valentini V, Poortmans P. Aristei C, et al. Among authors: masiello v. Crit Rev Oncol Hematol. 2023 Jul;187:104035. doi: 10.1016/j.critrevonc.2023.104035. Epub 2023 May 26. Crit Rev Oncol Hematol. 2023. PMID: 37244324 Free article. Review.
The 2018 assisi think tank meeting on breast cancer: International expert panel white paper.
Arenas M, Selek U, Kaidar-Person O, Perrucci E, Montero Luis A, Boersma L, Coles C, Offersen B, Meattini I, Bölükbaşı Y, Leonardi MC, Pfeffer R, Cutuli B, Vidali C, Franco P, Kouloulias V, Masiello V, Rivera S, Bourgier C, Ciabattoni A, Lancellotta V, Trigo L, Valentini V, Poortmans P, Aristei C. Arenas M, et al. Among authors: masiello v. Crit Rev Oncol Hematol. 2020 Jul;151:102967. doi: 10.1016/j.critrevonc.2020.102967. Epub 2020 Apr 22. Crit Rev Oncol Hematol. 2020. PMID: 32450277 Review.
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes.
Di Leone A, Terribile D, Magno S, Sanchez AM, Scardina L, Mason EJ, D'Archi S, Maggiore C, Rossi C, Di Micco A, Carnevale S, Paris I, Marazzi F, Masiello V, Orlandi A, Palazzo A, Fabi A, Masetti R, Franceschini G. Di Leone A, et al. Among authors: masiello v. J Pers Med. 2021 Apr 21;11(5):324. doi: 10.3390/jpm11050324. J Pers Med. 2021. PMID: 33919061 Free PMC article. Review.
The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy.
Arenas M, Bölükbaşı Y, Boersma LJ, Offersen B, Kouloulias V, Palumbo I, Trigo L, Lozza L, Marazzi F, Trovo M, Rivera S, Kaidar-Person O, Coles C, Meattini I, Valentini V, Aristei C, Poortmans P; Assisi Think Tank Meeting (ATTM) 2024 members. Arenas M, et al. Breast. 2025 Apr;80:103881. doi: 10.1016/j.breast.2025.103881. Epub 2025 Jan 20. Breast. 2025. PMID: 39854807 Free PMC article. Review.
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study.
Antonio F, Carbognin L, Paris I, Di Leone A, Orlandi A, Marazzi F, Mule A, Belli P, Rossi A, Magno S, Palazzo A, Masiello V, Santoro A, Fuso P, Bria E, D'Archi S, Scardina L, Sanchez AM, Giannarelli D, Paternello S, Garganese G, Scambia G, Tortora G, Masetti R, Franceschini G, Fabi A. Antonio F, et al. Among authors: masiello v. Future Oncol. 2025 Jul;21(17):2215-2223. doi: 10.1080/14796694.2025.2516410. Epub 2025 Jun 14. Future Oncol. 2025. PMID: 40515524
Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting.
Aristei C, Bölükbaşı Y, Kaidar-Person O, Pfeffer R, Arenas M, Boersma LJ, Ciabattoni A, Coles CE, Franco P, Krengli M, Leonardi MC, Marazzi F, Masiello V, Meattini I, Montero A, Offersen B, Trigo ML, Bourgier C, Genovesi D, Kouloulias V, Morganti AG, Meduri B, Pasinetti N, Pedretti S, Perrucci E, Rivera S, Tombolini V, Vidali C, Valentini V, Poortmans P. Aristei C, et al. Among authors: masiello v. Crit Rev Oncol Hematol. 2022 Sep;177:103774. doi: 10.1016/j.critrevonc.2022.103774. Epub 2022 Jul 30. Crit Rev Oncol Hematol. 2022. PMID: 35917884 Review.
51 results